<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Costa JV</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To determine the feasibility, acceptability, and preliminary efficacy of a 6-month tailored non-linear progressive physical activity intervention (PAI) for lymphoma patients undergoing chemotherapy.&lt;h4>Methods&lt;/h4>Patients newly diagnosed with lymphoma (non-Hodgkin (NHL) or Hodgkin (HL)) were randomized into the PAI or healthy living intervention (HLI) control (2:1). Feasibility was assessed by examining accrual, adherence, and retention rates. Participants completed assessments of exercise capacity (VO&lt;sub>2&lt;/sub> peak and 6-min walk distance (6MWD)), objective and self-reported levels of physical activity, MRI-derived cardiovascular functioning (Left Ventricular Ejection Fraction [LVEF], stroke volume, and cardiac output), and self-reported health-related and disease-s</pubmed_abstract><journal>Pilot and feasibility studies</journal><pagination>6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11731389</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment.</pubmed_title><pmcid>PMC11731389</pmcid><pubmed_authors>Hundley WG</pubmed_authors><pubmed_authors>Wolle BR</pubmed_authors><pubmed_authors>Franco RL</pubmed_authors><pubmed_authors>Vaidya R</pubmed_authors><pubmed_authors>D'Agostino R</pubmed_authors><pubmed_authors>Lucas AR</pubmed_authors><pubmed_authors>Wagner L</pubmed_authors><pubmed_authors>Seegars MB</pubmed_authors><pubmed_authors>Via J</pubmed_authors><pubmed_authors>Costa JV</pubmed_authors><pubmed_authors>Marshall A</pubmed_authors><pubmed_authors>Leitzelar B</pubmed_authors><pubmed_authors>Norton S</pubmed_authors><pubmed_authors>Brubaker PH</pubmed_authors><pubmed_authors>Yazbeck V</pubmed_authors><pubmed_authors>Mihalko SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment.</name><description>&lt;h4>Background&lt;/h4>To determine the feasibility, acceptability, and preliminary efficacy of a 6-month tailored non-linear progressive physical activity intervention (PAI) for lymphoma patients undergoing chemotherapy.&lt;h4>Methods&lt;/h4>Patients newly diagnosed with lymphoma (non-Hodgkin (NHL) or Hodgkin (HL)) were randomized into the PAI or healthy living intervention (HLI) control (2:1). Feasibility was assessed by examining accrual, adherence, and retention rates. Participants completed assessments of exercise capacity (VO&lt;sub>2&lt;/sub> peak and 6-min walk distance (6MWD)), objective and self-reported levels of physical activity, MRI-derived cardiovascular functioning (Left Ventricular Ejection Fraction [LVEF], stroke volume, and cardiac output), and self-reported health-related and disease-s</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-01T14:36:51.702Z</modification><creation>2025-04-06T01:14:26.75Z</creation></dates><accession>S-EPMC11731389</accession><cross_references><pubmed>39810280</pubmed><doi>10.1186/s40814-024-01580-7</doi></cross_references></HashMap>